Strides Sells Majority Stake in Pivot Path, Partners With Ascent Capital To Fuel Future Growth
Published on: June 28, 2026, 9:51 a.m. | Source: Free Press Journal
Strides Pharma Science has partnered with Ascent Capital to unlock value in its subsidiary Pivot Path. The deal includes a stake sale worth Rs 100 crore and a fresh capital infusion of Rs 50 crore to support business expansion and long-term growth.
